| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |